Press Releases

Press Releases

Date Title and Summary Additional Formats
Jan 10, 2022 Catalyst Pharmaceuticals Announces 11th Circuit Court of Appeals Denial of Jacobus Pharmaceutical Company Inc.'s Petition for Rehearing
CORAL GABLES, Fla. , Jan. 10, 2022 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare
Jan 04, 2022 Catalyst Pharmaceuticals to Participate in January 2022 Virtual Investor Conferences
CORAL GABLES, Fla. , Jan. 04, 2022 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals , Inc. (Catalyst) (Nasdaq: CPRX), a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare